9 exercise testing and training in patients with malignant arrhythmias

Exercise and Sport Sciences Reviews

Volumn 25, Issue 1, 1997, Pages 235-270

  Pashkow, Fredric J ^a   Schweikert, Robert A ^a   Wilkoff, Bruce L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATOR; EXERCISE; EXERCISE TEST; HEART ARRHYTHMIA; HEART RATE; HUMAN; PATHOPHYSIOLOGY; PHYSICAL EDUCATION; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; EXERCISE; EXERCISE TEST; HEART RATE; HUMANS; PHYSICAL EDUCATION AND TRAINING; PRACTICE GUIDELINES; RISK FACTORS;

EID: 0030630853     PISSN: 00916331     EISSN: 15383008     Source Type: Journal    
DOI: 10.1249/00003677-199700250-00011     Document Type: Article

References (55)

1. Akhtar, M., I. Niazi, G. V. Mac carelli, et al. Role of adrenergic stimulation bv i soproterenol in reversal of effects of encainide in supraventricular tachycardia Am. J Cardiol. 62:451-461, 1988
2. Allen, B.J., T. P. Gusev, M. A. Brodsky, C R. Luckett, and W. L. Henry. Exercise testing in patients with life-threatening ventricular tachyarrhythmias: results and correlation with clinical and arrhythmia factors. Am. Heart. J 116:997-1002, 1988.
3. American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation Programs. Champaign, IL: Human Kinetics Books, 1995, p. 27.
4. American College ol Cardiology. Position report mi cardiac rehabilitation.J Am. Coll. Car dial. 7:451-453, 1986.
5. American College ol Sports Medicine: Guidelines lor Exercise Testing and Prescription. Philadelphia: Lea & Febigei. 1991.
6. Amsterdam, E. A. Relation of silent myocardial ischemia to ventricular arrhythmias and sudden death. Am. J. Cardiol. 62:241-271, 1988.
7. Anonymous: Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. MADIT Executive Committee. PACE. Paring Clin. Elritrophysiol. 14:920-927, 1991
8. Anonymous: AntiarrhythmicS;Versus Implantable Defibrillators (AVID)-rationale, design, and methods. Am. J. Cardiol 75:470-475, 1995.
9. Badger, J. M., and I.I. Monts. Observations of a support group for automatic implantable cardioverter- 1 librillatoi recipients and then spouses. Heart Lung18:238-243, 1989.
10. Beard, E. F., and C. A. Owen. Cardiac arrhythmias during exercise testing in healthy men. AnmJjare Med 44:286-289, 1973.
11. Busbt, M.J., E. A. Shelrin, and J. L. Fleg. Prevalence and long-term significance of exer-i ise indueed frequent or repetitive ventricular ectopic beats in apparently healthy voiun-teers. J. Am. Colh Cardiol 14:4659-4665,1989.
12. Califf, R. M., R. A. McKinnts, J.F. McNeer, et al. Prognostic value of ventricular arrhvth-mias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease, J. Am. Coll. Cardiol, 2:1064-1067, 1983.
13. Callans, J. and M. E. Josephson. Future developments in implantable cardioverter defibrillators: the optimal device. Prog. CaWiovqsc. Disi 36:227-244, 1093.
14. Cohen, T. W., W. Chien, K. G. Lurie, et al. Implantable cardioverter defibrillaSisr pi oat-rhvthmia: case report and review of the literature. PACE Pacing Clin. EUrtrophysiol. 14:1326-1329,1991.
15. Cianefield, P. F., A. L. Wit, and B. I. Hoffman. Genesis of cardiac arrhythmias. Circulation 17:190-204. 1973.
16. UeBorde, R, J. H. Levine, L.S.C. Griffith, et al. Exercise testing in patients with automatic implantable cardioverter defibrillators (abstract). J. Am. Coll. Cardiol. 9:169A. 1987.
17. Detrv, J. M., and D. Dejonghe Exercise testing in the evaluation ol ventricular arrhyth-mias in Coronary arterv disease Eur. Heart J, 8:55-59, 1987
18. Fabian, J., Hstolz, M., Janota, J., and J. Rohac. Reproducibility ol exercise tests in patients with symptomatic ischaemic heart disease Mr. Heart J 37:785-789, 1975.
19. Falcone, D., S. de Seni, I. Poma, et al Clinical significance ol exercise-induerd silent im-ocardial ischemia in patients with coronary artery disease. J Am. Coll. Cardiol. 9:295-299.1987.
20. Fintel, D., E. Griffith, E. Platia, C. Kullman, and P. Reid. Exercise-induced ventricular tachycardia does not predict outcome in patients with recurrent ventricular tachycardia or fibrillation. PACE Paring Clin. Electrophysiol. 7:459, 1984.
21. Fioretti, P., Deckers, D., T. Baardman, et al. Incidence and prognostic implications of repetitive ventricular complexes during pre-discharge bicycle ergometry after myocardial infarction. Ear. Heart. J. 8:51-54, 1987.
22. Fletcher, G. F., G. Balady, V. F Froelicher, L. H. Hartley, W. E. Haskell, and M. L. Pollock. Exercise standards: a statement for healthcare professionals from the American Heart Association. Circulation 91:580-615, 1995.
23. Froelicher, E. S. Usefulness of exercise testing shortly after acute myocardial infarction for predicting 10-year mortality. Am. j. Cardiol. 74:318-323, 1994.
24. Gibbons, L., S. N. Blair, H. W. Kohl, and H Cooper. The safety ol maximal exercise testing. Circulation 80:846-852, 1989.
25. Gooch, A. S., and D. McConnell. Analysis of transient arrhythmias and conduction disturbances occurring during submaximal treadmill exercise testing. Prog. Cardiovasc. Dis. 13:293-307, 1970.
26. Graboys, T. B., B. Lown, P. J. Podrid, and R. DeSilva. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am. J. Cardiol. 50:437-443, 1982.
27. Grimm, W., B. T. Flores, and F. E. Marchlinski. Shock occurrenc e and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 87:188b-1888, 1993.
28. Hammel, D., M. Block, A. Geiger, et al. Single-incision implantation of cardioverter defibrillators using nonthoracotomy lead systems [see comments], Ann. home. burg. 58:1614-1616, 1994.
29. Haskell, W., Cardiovascular complications during exercise training of cardiac patients. Circulation 57:920-924, 1978.
30. Hauswirth, D., D. Noble, and R. W. Tsien, Adrenaline mechanism of action of the pace-maker potential in cardiac Purkinje fibers. Science 162:916, 1968.
31. Hcmdeghem, L. M., and B. G. Katzung. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu. Rev. Pharmacol. Toxnol 24-387-423, 1984.
32. Kalbfleisch, K. K., M. H. Lehmann, R. T. Steinman, and et al. Reemployment following implantation of the automatic cardioverter-defibrillator. Am. J. Cardiol. 64:199-202, 1989.
33. Kelly, T. M., Menard Rothe, C. Callahan, A. Klapperich, and R. White. Outpatient exercise training in cardiac patients with malignant arrhythmias. J. Cardiopuhn. Rehabii. 18:395, 1989.
34. Kleiger, R. E., J.P. Miller, J. J. Bigge, and A. J. Moss. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 59:256-262, 1987.
35. Kleiger, R.E., J. F. Miller, R. J. Krone, and J. J. Bigger. The independenceof cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction. the multicenter postinfarction research group. am. j. Cardiol. 65:408-411,1990.
36. Krone, R.J., J. A. Gillespie, F. M Weld, J. P. Miller, and A. J. Moss. Low-level exercise test-tng aflei myocardial infarction: usefulness, in enhancing clinical risk stratification. Circulation 71:80-89, 1985.
37. McHetm, P. L., C. Fisrh, and J. W. Jordan. Cardiac arrhuhmia observed during maximal exercise testing in clinically normal men. Am. j. Cardiol. 39:311, 1978.
38. Nadetnanee, X., B. X. Singh, W. C. Sleyenson, and J. N. Weiss. Aimodarone and post-mv-ocarclial infarction patients. Circulation 88:764-774. 1993.
39. Pashbow, F. J. Rehabilitation of the cardiologicallv complex patient-left ventricular dysfunction. arrhythmia, and valvular heart disease. F. J. Pashkoyv and W. A. Dafoe (eds.). Chniral Carthtu Rehabilitation: A Cardiologist's mde Baltimore: Williams & Wilkins, 1993.
40. PCD Investigator Group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study-. J. Am. Coll. Cardiol 23:1521-1530, 1994.
41. Pina, I. L., G. J. Balady, P. Hanson, A. J. Labovitz, D. W. Madonna, and J. Myers, Guidelines for clinical exercise testing laboratories. A statement for healthcare professionals from the Committee on Exercise and Cardiac Rehabilitation, American Heart Association. Circulation 91:912-921, 1995.
42. Pinski, S. L., and G. J. Faby. The proarrhylhmic potential of implantable cardioverter-defibrillators. Circulation 92:1651-1664, 1995.
43. Pinski, S. L., and R. G. Trohman, Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist. Ann. Intern. Med. 122:770-777, 1995.
44. Poblete, P. F., H. L. Kennedy, and D. G. Caralis. Detection of ventricular ectopy in patients with coronary' heart disease and normal subjects by exercise testing and ambulatory electrocardiography. Chest 74:402-407, 1978.
45. Podrid, P. J., F. J. Venditti, P. A. Levine, and M. D. Klein. The role of exercise testing in evaluation of arrhythmias. Am. J. Cardiol. 62:2111-3311. 1988.
46. Pycha T and et al. Psychological responses to the implantable defibrillator. Psyghoso-matics 27:841-815, 1986.
47. Ranger, S., M. Talajit, R. Iemery, D. Roy, C. Villemaire, and S. Nattel. Kinetics of use-dependent ventricular conduction slowing by an arrhythmic drugs in humans. Circulation 83:1987-1994, 1991.
48. Ryan, M., B. Town, and H. Horn. Comparison of ventricular ectopic activity during 24-hour monitoring and exercise testing in patients with coronary heart disease. N. Engl. J. Med. 292:224-229, 1975.
49. Schlant, R. C., G. C. I. Friesinger, and J. J. Leonard. Clinical competence in exercise testing: a statement for physicians from the ACPJAGCJAHAjTask Force oniClinical Privileges in Cardiology. J. Am. Coll. Cardiol. 16:1061-1065, 1990.
50. Schmitt, C., M. Monterp, and J. Melichercik. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. PACE Penang Clin. Electrophysiol. 17:208-302, 1994.
51. Schwartz, P. J. Manipulation ol the autonomic nervous system in the prevention of sudden cardiac death. P, W. Brugada and H. J. Wellens (eds.). Cardiac Arrhythmias: Where Do We Go pram Herd New York: Futura, 1987, pp. 741-765.
52. Shepsit, S., J. C. Ernst, IR. Briese, et al. Decreased iiequencv of exit rise-indut ed ventricular ectopic activity in the second of two consecutive treadmill tests. Circulation 55:892-895, 1977.
53. Slater, W., S. Lampert, P J. Podrid, and B. Lown. Clinical predictors of arrhythmia worsening by antiarrhythmic drags. Am. J. Cardiol. 61:349-353, 1988.
54. Young, D. Z., S. Lampert, T. B. Grahovs, and B. Eovvn. Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia. Cirrulatmn 70:184-191, 1984.
55. Zipes, D. Genesis of cardiac arrhuhmias: elcctrophvsiological considerations, E. Braun-wald (ed.). Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: W. B. Saunders, 1992, vol. 1, pp. 588-627.